BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24897995)

  • 1. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.
    Fong ZV; Tanabe KK
    Cancer; 2014 Sep; 120(18):2824-38. PubMed ID: 24897995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
    Yu SJ
    Clin Mol Hepatol; 2016 Mar; 22(1):7-17. PubMed ID: 27044761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.
    Poon D; Anderson BO; Chen LT; Tanaka K; Lau WY; Van Cutsem E; Singh H; Chow WC; Ooi LL; Chow P; Khin MW; Koo WH;
    Lancet Oncol; 2009 Nov; 10(11):1111-8. PubMed ID: 19880065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
    Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
    Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of hepatocellular carcinoma and current treatment options.
    Raoul JL
    Semin Nucl Med; 2008 Mar; 38(2):S13-8. PubMed ID: 18243838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011.
    Song P; Tobe RG; Inagaki Y; Kokudo N; Hasegawa K; Sugawara Y; Tang W
    Liver Int; 2012 Aug; 32(7):1053-63. PubMed ID: 22432445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
    Zhao C; Nguyen MH
    J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation.
    Song P; Tang W; Tamura S; Hasegawa K; Sugawara Y; Dong J; Kokudo N
    Biosci Trends; 2010 Dec; 4(6):283-7. PubMed ID: 21248425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
    Ikai I
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular cancer: a guide for the internist.
    Parikh S; Hyman D
    Am J Med; 2007 Mar; 120(3):194-202. PubMed ID: 17349437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017.
    Song P; Cai Y; Tang H; Li C; Huang J
    Biosci Trends; 2017; 11(4):389-398. PubMed ID: 28904327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaping the future management of hepatocellular carcinoma.
    Abou-Alfa G; Colombo M
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma - current aspects of screening, surveillance and therapeutic strategies (revised EASL-EORTC recommendations)].
    Roeb E
    Zentralbl Chir; 2014 Apr; 139(2):175-83. PubMed ID: 24132679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.